Long-Term Prevention Of Recurrences Of Venous Thromboembolic Complications In Clinical Oncology
Thromboses have a significant impact both on the progression of malignant tumor and on the results of the anti-tumor therapy. The modern achievements of clinical oncology demonstrate the necessity of an active prevention of thromboembolic complications at each stage of the complex and combination treatment. This determines the feasibility of the use of long-lasting regimens of prevention of thromboembolic complications and their possible recurrences in particular. Therewith cumulative toxicity of separate methods of anti-cancer therapy, that influence thrombus formation must be taken into consideration. The article presents the most optimal methods of active prevention of thromboembolic complications at each stage of the complex and combination treatment. In the conclusion the author states that with an adequate thrombus prevention it is possible to control the risk of the occurrence of venous thromboembolic complications successfully not only after surgical interventions but during conducting of other methods of anti-cancer treatment.